Get started
Markets US Stocks Health Technology Medical Specialties

AtriCure, Inc ATRC

ATRC NASDAQ
ATRC
AtriCure, Inc NASDAQ
See more on advanced chartSee more on advanced chart
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
News Ideas Financials Technicals

ATRC Chart

Trade ATRC with trusted brokers on TradingView Open account

Ideas

$ATRC - add to watch list
ATRC
, 1W
ATRC: $ATRC - add to watch list

The stock has been declining since November 2021. I see its downside target as an uptrend line with the price at $56.7. There I would consider buying, as the stop will be small, with the subsequent growth to the level of $69 At the moment, the 100W EMA provides support. My opinion is to put it in the WatchList.

Atrc
ATRC
, 1WLong
ATRC: Atrc

Ready to go

Breakout Algo Buy Signal
ATRC
, 1WLong
ATRC: Breakout Algo Buy Signal

Not Trading or Investment Advice!!! My breakout algo issued a buy signal on 6/5. Buy at 50.27 Wait for update on exit price Risk control: use 3% of portfolio capital

ATRC BUY 45.06$ SL 40$
ATRC
, 1DLong
ATRC: ATRC BUY 45.06$ SL 40$

May-08-20 08:47AM AtriCure Announces Results from CONVERGE IDE Clinical Trial Business Wire +7.70%

ATRC long
ATRC
, DLong
ATRC: ATRC long

ATRC long

ATRC bounces off support, going higher on bullish momentum
ATRC
, DLong
ATRC: ATRC bounces off support, going higher on bullish momentum

Historically, $22.50 is a very significant level for ATRC. It was former resistance at the beginning of 2014 and end of 2015, and is currently support for the current rally upward. We have already bounced off that level and the most likely outcome is the trend continuing upward to a target of $26.32. Here's the trade: Buy: $23.45 Stop: $22.50 Target: $26.32

AtriCure - New Hights very soon!
ATRC
, WLong
ATRC: AtriCure - New Hights very soon!

Follow me to see my ideas.

Technicals

Analyst rating

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Medical Specialties
AtriCure, Inc. engages in the development, manufacture, and sale of devices designed primarily for the surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in Mason, OH.

Breaking news

More news